您要查找的是不是：
- Non small lung cancer 非小细胞肺癌
- Monzo M, Rosell R, Taron M. Drug resistance in non small cell lung cancer. Lung Cancer,2001,34 Suppl 2 : S91-S94. [韩宝惠;廖美琳;苏建中;等.;非小细胞肺癌肿瘤药敏与耐药
- Gemcitabine is a new active drug in the treatment of advanced non small cell lung cancer (NSCLC). 吉西他滨是近年来治疗晚期非小细胞肺癌的有效新药。
- Purpose:To compare the therapeutic effects of VP and MVP regimen for the treatment of non small cell lung cancer(NSCLC). 目的：比较VP方案与MVP方案对非小细胞肺癌（NSCLC）的治疗效果。
- OBJECTIVE:To study the clinical significance of BCG PSN combined with operation or chemotherapy in treating non small cell lung cancer(NSCLC). 目的 :探讨卡介菌核糖核酸 (BCG PSN)与手术或化疗联合治疗非小细胞肺癌 (non smallcelllungcancer ,NSCLC)的临床意义。
- Objective To investigate the correlation between BRI gene expression and the metastatic potential in human non small cell lung cancer cell lines. 目的 研究BRI基因在人非小细胞肺癌细胞系中的表达 ,探讨其表达情况与肺癌转移能力的相关性。
- Objective To study the expression of survivin and its relationship with expression of P53,c myc,k ras in non small cell lung cancer(NSCLC). 目的 探讨survivin基因在非小细胞肺癌 (NSCLC)中的表达 ,及与P5 3、c myc、k ras蛋白表达的相互关系。
- Objective To study the clinical application value of advanced non small cell lung cancer treated with Gem,NVB and DDP regimen. 目的:研究健择、诺维本、顺铂三药联合治疗晚期非小细胞肺癌的临床应用价值。
- Objective To study the clinical application value of advanced non small cell lung cancer treated with Gem, NVB and DDP regimen. 摘要目的：研究健择、诺维本、顺铂三药联合治疗晚期非小细胞肺癌的临床应用价值。
- Objective To evaluate near therapeutic effect of advanced non small cell lung cancer(NSCLC), treated with NP regimen or EP regimen. 目的探讨NP与EP方案对晚期非小细胞肺癌的近期疗效。
- To evaluate the efficacy and toxicity of NIP(NVB+IFO+DDP)regimen in the treatment for advanced non small cell lung cancer(NSCLC). 观察异长春花碱(NVB)、异环磷酰胺(IFO)和顺铂(DDP)联合化疗(即NIP方案),治疗晚期非小细胞肺癌的疗效及毒副反应。
- AIM: To study the efficiency and toxicities of docetaxel gemcitabine combination on advanced non small cell lung cancer (NSCLC). 目的:研究健择和多西紫杉醇联合方案治疗晚期非小细胞肺癌(NSCLC)的疗效。
- Purpose:To evaluate the efficacy and toxicity of using lobaplatin, a new chemotherapy drug of ASTA Company,to treat small cell and non small cell lung cancer. 评价德国ASTA药物公司研制的新化疗药物乐铂对小细胞及非小细胞肺癌的治疗效果和不良反应。
- Schiller JH,Harington D,Belanie CP,et al.Compmison of four chemotherapy regimens for advanced non small cell lung cancer[J].New Eng J Med,2002,346(2):92-98. 王延红;卢雨霖;李若英.;紫杉醇联合顺铂治疗晚期非小细胞肺癌疗效观察[J]
- Objective To investigate the mechanism of the adhesion molecules in peripheral blood in hematogenous metastasis of elderly patients with non small cell lung cancer. 目的研究老年人非小细胞肺癌血行转移时粘附分子的作用。
- Objective To study effect of combined therapy of Kanglaite on quality of life (QOL) of middle old aged patients with advanced non small cell lung cancer(NSCLC). 目的观察康莱特联合化疗对中老年晚期非小细胞肺癌患者生存质量的影响。
- Objective:To observe the efficacy and toxicity of domestic epirubicin in treatment of non Hodgkin's lymphoma,breast cancer,and non small cell lung cancer. 目的:观察国产表柔比星为主的联合化疗方案治疗非霍奇金淋巴瘤、乳腺癌、非小细胞肺癌的疗效和不良反应。
- The frequence of intragenic homozygous deletions of DMBT1 of non small cell lung cancer group were higher than that of small cell lung cancer group ( P < 0.05 ). DMBT1基因纯合性缺失率非小细胞肺癌组高于小细胞肺癌组;低、未分化肺癌组高于中、高分化肺癌组;伴有淋巴和/或远处转移组高于不伴转移组;有吸烟史组高于无吸烟史组(P均<0。
- Objective To evaluate the efficacy and toxicity of combination chemotherapy of navelbine(NVB)? ifosfamide(IFO)and cisplatin(PDD) in the treatment of advanced non small cell lung cancer (NSCLC). 目的 :观察诺维本 (NVB)、异环磷酰胺 (IFO)、顺铂 (PDD)三药联合 (NIP方案 )治疗晚期非小细胞肺癌的疗效和毒性。
- Objective To observe the efficacy and safety of navelbine (NVB) combined with ifosfamide (IFO) and cisplatin (DDP) (NIP regimen) and IFO plus DDP (IP regimen) for advanced non small cell lung cancer (NSCLC). 目的 观察诺维本 (NVB)、异环磷酰胺 (IFO)、顺铂 (DDP)组成的NIP方案和IFO、DDP组成的IP方案治疗晚期非小细胞肺癌的疗效和安全性。
